FP7
EUROTARGET
European collaborative project on Targeted therapy in renal cell cancer: genetic and tumor-related biomarkers for response and toxicity
- Programme
- Seventh Framework Programme
- Started
- Ends
- Duration
- 66 months
- Total cost
- EUR 7,818,367
- EU contribution
- EUR 5,999,550
- Participants
- 15 from 8 countries
- Topic
- FP7_HEALTH.2010.2.4.1-8
- Grant agreement
- 259939
Coordinated by Stichting Radboud Universiteit (NLNetherlands).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Stichting Radboud Universiteit | NLNetherlands | Coordinator | EUR 1,792,400 | known name (0.95) |
| Cesar Central European Society for Anticancer Drug Research Ewiv | ATAustria | Participant | EUR 521,475 | PIC (1.00) |
| Rheinische Friedrich-Wilhelms-Universitat Bonn | DEGermany | Participant | EUR 163,200 | known name (0.97) |
| Universitat des Saarlandes | DEGermany | Participant | EUR 428,129 | known name (0.95) |
| Universitatsklinikum Jena | DEGermany | Participant | EUR 82,172 | known name (0.97) |
| Fundacio Institut D'Investigacio Biomedica de Bellvitge | ESSpain | Participant | EUR 550,000 | known name (0.95) |
| Grupo Espanol de Tratamiento de Tumores Urologicos Asociacion | ESSpain | Participant | EUR 97,125 | PIC (1.00) |
| Institut National de la Sante et de la Recherche Medicale | FRFrance | Participant | EUR 80,000 | known name (0.95) |
| Cambridge University Hospitals NHS Foundation Trust | GBUnited Kingdom | Participant | EUR 327,648 | known name (0.95) |
| The Chancellor Masters and Scholars of the University of Cambridge | GBUnited Kingdom | Participant | EUR 19,152 | known name (0.95) |
| Islensk Erfdagreining Ehf | ISIceland | Participant | EUR 787,550 | PIC (1.00) |
| Academisch Ziekenhuis Leiden | NLNetherlands | Participant | EUR 258,000 | PIC (1.00) |
| Pamgene International BV | NLNetherlands | Participant | EUR 471,500 | PIC (1.00) |
| Stichting het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis | NLNetherlands | Participant | EUR 373,200 | known name (0.95) |
| Universitatea de Medicina Si Farmacie Carol Davila Din Bucuresti | RORomania | Participant | EUR 48,000 | known name (0.95) |
Changes of the consortium
First seen on with 15 participants from 8 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.